This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Cheil Foods & Chemicals, Inc., Cj Corporation, Korea Institute of Science and Technology. Active years: 1996-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Inchun, KR (1996)
- Seoul, KR (1998 - 2006)
Company Filing History:


Years Active: 1996-2006
Title: Innovations of Jung Woo Suh
Introduction
Jung Woo Suh is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of methods for purifying antibiotics. With a total of three patents to his name, his work has had a meaningful impact on medical science.
Latest Patents
One of his latest patents is a process for purifying vancomycin hydrochloride. This method involves purifying vancomycin from a fermentation broth of a microorganism containing the antibiotic. The process includes passing the fermentation broth through a strong acid cation exchange resin, a weak base anion exchange resin, alumina, and a hydrophobic absorbent resin sequentially. Another significant patent is for the antifungal antibiotic cepacidine A, which showcases his innovative approach to antibiotic development.
Career Highlights
Throughout his career, Jung Woo Suh has worked with prominent organizations such as Cheil Foods & Chemicals, Inc. and the Korea Institute of Science and Technology. His experience in these institutions has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
He has collaborated with notable colleagues, including Yoong H Lim and Yong W Lee, which has further enriched his research and development efforts.
Conclusion
Jung Woo Suh's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of essential medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile